DDInter

DDInter catalogs clinically relevant drug-drug interaction (DDI) data to support identification, annotation, and analysis of DDIs for clinical and research use.

Key Features:

• Extensive DDI Associations: DDInter contains approximately 240,000 curated DDI associations involving 1833 approved drugs (1972 entities).
• Detailed Annotations: Each drug entry includes basic chemical and pharmacological information and an interaction network; each DDI is annotated with severity, mechanisms, management strategies, and alternative medications.
• Visualization Tools: Provides visualization tools for interaction networks and related annotation data.
• Prescription Checking Functionality: Enables evaluation of whether specific drug combinations can be used safely by assessing annotated interaction information.
• Cross-Linking of Entities: Cross-links drug entities and interaction entities to connect related drugs, interactions, and annotations.

Scientific Applications:

• Clinical decision support: Supports clinicians in assessing interaction severity and management to inform prescribing decisions.
• Informatics-based DDI investigations: Enables computational studies of DDI patterns and networks using curated association data.
• Benchmarking prediction frameworks: Provides annotated DDI data for evaluating and benchmarking DDI prediction methods.
• Pharmacological interaction studies: Facilitates investigation of mechanisms underlying pharmacological interactions.
• Drug safety research: Supports research into drug safety, adverse event mitigation, and alternative medication strategies.

Methodology:

Curated by integrating extensive data sources with expert annotations, with a focus on clinically significant DDIs.